[1]
|
Sheen, C.L., Lamparelli, H., Milne, A., Green, I. and Ramage, J.K. (2000) Clinical Features, Diagnosis and Outcome of Acute Portal Vein Thrombosis. QJM, 93, 531-534. https://doi.org/10.1093/qjmed/93.8.531
|
[2]
|
Condat, B., Pessione, F., Helene Denninger, M., Hillaire, S. and Valla, D. (2000) Recent Portal or Mesenteric Venous Thrombosis: Increased Recognition and Frequent Recanalization on Anticoagulant Therapy. Hepatology, 32, 466-470. https://doi.org/10.1053/jhep.2000.16597
|
[3]
|
Francoz, C., Belghiti, J., Vilgrain, V., et al. (2005) Splanchnic Vein Thrombosis in Candidates for Liver Transplantation: Usefulness of Screening and Anticoagulation. Gut, 54, 691-697. https://doi.org/10.1136/gut.2004.042796
|
[4]
|
Okuda, K., Ohnishi, K., Kimura, K., et al. (1985) Incidence of Portal Vein Thrombosis in Liver Cirrhosis. An Angiographic Study in 708 Patients. Gastroenterology, 89, 279-286. https://doi.org/10.1016/0016-5085(85)90327-0
|
[5]
|
Stine, J.G., Argo, C.K., Pelletier, S.J., Maluf, D.G., Caldwell, S.H. and Northup, P.G. (2017) Advanced Non-Alcoholic Steatohepatitis Cirrhosis: A High-Risk Population for Pre-Liver Transplant Portal Vein Thrombosis. World Journal of Hepatology, 9, 139-146. https://doi.org/10.4254/wjh.v9.i3.139
|
[6]
|
Stine, J.G., Shah, N.L., Argo, C.K., Pelletier, S.J., Caldwell, S.H. and Northup, P.G. (2015) Increased Risk of Portal Vein Thrombosis in Patients with Cirrhosis Due to Nonalcoholic Steatohepatitis. Liver Transplantation, 21, 1016-1021. https://doi.org/10.1002/lt.24134
|
[7]
|
Ruiz, P., Sastre, L., Crespo, G., et al. (2017) Increased Risk of Portal Vein Thrombosis in Patients with Autoimmune Hepatitis on the Liver Transplantation Waiting List. Clinical Transplantation, 31, e13001. https://doi.org/10.1111/ctr.13001
|
[8]
|
Balfour, G.W. and Stewart, T.G. (1869) Case of Enlarged Spleen Compli-cated with Ascites, Both Depending upon Varicose Dilatation and Thrombosis of the Portal Vein. Edinburgh Medical Journal, 14, 589-598.
|
[9]
|
Chawla, Y.K. and Bodh, V. (2015) Portal Vein Thrombosis. Journal of Clinical and Ex-perimental Hepatology, 5, 22-40. https://doi.org/10.1016/j.jceh.2014.12.008
|
[10]
|
Zocco, M.A., Di Stasio, E., De Cristofaro, R., Novi, M., Ainora, M.E., Ponziani, F., Riccardi, L., Lancellotti, S., Santoliquido, A., Flore, R., Pompili, M., Rapaccini, G.L., Tondi, P., Gasbarrini, G.B., Landolfi, R. and Gasbarrini, A. (2009) Thrombotic Risk Factors in Patients with Liver Cirrhosis: Correlation with MELD Scoring System and Portal Vein Thrombosis Development. Journal of Hepatology, 51, 682-689. https://doi.org/10.1016/j.jhep.2009.03.013
|
[11]
|
Stine, J.G., Wang, J., Shah, P.M., Argo, C.K., Intagliata, N., Uflacker, A., Caldwell, S.H. and Northup, P.G. (2018) Decreased Portal Vein Velocity Is Predictive of the Development of Portal Vein Thrombosis: A Matched Case-Control Study. Liver International, 38, 94-101. https://doi.org/10.1111/liv.13500
|
[12]
|
Maruyama, H., Okugawa, H., Takahashi, M. and Yokosuka, O. (2013) De Novo Portal Vein Thrombosis in Virus-Related Cirrhosis: Predictive Factors and Long-Term Outcomes. American Journal of Gastroenterology, 108, 568-574. https://doi.org/10.1038/ajg.2012.452
|
[13]
|
Nery, F., Correia, S., Macedo, C., Gandara, J., Lopes, V., Valadares, D., Ferreira, S., Oliveira, J., Gomes, M.T., Lucas, R., Rautou, P.E., Miranda, H.P. and Valla, D. (2019) Nonselective Beta-Blockers and the Risk of Portal Vein Thrombosis Inpatients with Cirrhosis: Results of a Prospective Longitudinal Study. Alimentary Pharmacology & Therapeutics, 49, 582-588. https://doi.org/10.1111/apt.15137
|
[14]
|
Zampino, R., Lebano, R., Coppola, N., Macera, M., Grandone, A., Rinaldi, L., De Sio, I., Tufano, A., Stornaiuolo, G., Adinolfi, L.E., Durante-Mangoni, E., Battista, G.G. and Niglio, A. (2018) The Use of Nonselective Beta Blockers Is a Risk Factor for Portal Vein Thrombosis in Cirrhotic Patients. Saudi Journal of Gastroenterology, 24, 25-29. https://doi.org/10.4103/sjg.SJG_100_17
|
[15]
|
Violi, F., Corazza, G.R., Caldwell, S.H., Perticone, F., Gatta, A., Angelico, M., Farcomeni, A., Masotti, M., Napoleone, L., Vestri, A., Raparelli, V. and Basili, S. (2016) Portal Vein Thrombosis Relevance on Liver Cirrhosis: Italian Venous Thrombotic Events Registry. Internal and Emergency Medi-cine, 11, 1059-1066. https://doi.org/10.1007/s11739-016-1416-8
|
[16]
|
Yoshimatsu, R., Yamagami, T., Tanaka, O., et al. (2012) De-velopment of Thrombus in a Systemic Vein after Balloon-Occluded Retrograde Transvenous Obliteration of Gastric Varices. Korean Journal of Radiology, 13, 324-331. https://doi.org/10.3348/kjr.2012.13.3.324
|
[17]
|
DeLeve, L.D., Valla, D.-C. and Garcia-Tsao, G. (2009) Vascular Disorders of the Liver. Hepatology, 49, 1729-1764. https://doi.org/10.1002/hep.22772
|
[18]
|
Barbui, T., Finazzi, G. and Falanga, A. (2013) Myeloproliferative Neo-plasms and Thrombosis. Blood, 122, 2176-2184. https://doi.org/10.1182/blood-2013-03-460154
|
[19]
|
Falanga, A. and Marchetti, M. (2012) Thrombotic Disease in the Myeloproliferative Neoplasms. Hematology—American Society of Hematology Education Program, 2012, 571-581. https://doi.org/10.1182/asheducation.V2012.1.571.3798557
|
[20]
|
Arellano-Rodrigo, E., Alvarez-Larrán, A., Re-verter, J.C., Villamor, N., Colomer, D. and Cervantes, F. (2006) Increased Platelet and Leukocyte Activation as Con-tributing Mechanisms for Thrombosis in Essential Thrombocythemia and Correlation with the JAK2 Mutational Status. Haematologica, 91, 169-175.
|
[21]
|
Robertson, B., Urquhart, C., Ford, I., et al. (2007) Platelet and Coagulation Activa-tion Markers in Myeloproliferative Diseases: Relationships with JAK2 V6I7 F Status, Clonality, and Antiphospholipid Antibodies. Journal of Thrombosis and Haemostasis, 5, 1679-1685. https://doi.org/10.1111/j.1538-7836.2007.02626.x
|
[22]
|
Saugel, B., Lee, M., Feichtinger, S., Hapfelmeier, A., Schmid, R.M. and Siveke, J.T. (2015) Thrombophilic Factor Analysis in Cirrhotic Patients with Portal Vein Thrombosis. The Journal of Thrombosis and Thrombolysis, 40, 54-60. https://doi.org/10.1007/s11239-014-1124-z
|
[23]
|
Amitrano, L., Brancaccio, V., Guardascione, M.A., Margaglione, M., Sacco, M., Martino, R., De Nucci, C., Mosca, S., Iannaccone, L., Ames, P.R., Romano, L. and Balzano, A. (2002) Portal Vein Thrombosis after Variceal Endoscopic Sclerotherapy in Cirrhotic Patients: Role of Genetic Thrombophilia. Endoscopy, 34, 535-538. https://doi.org/10.1007/s11239-014-1124-z
|
[24]
|
Erkan, O., Bozdayi, A.M., Disibeyaz, S., Oguz, D., Ozcan, M., Bahar, K., Karayalcin, S., Ozden, A., Bozkaya, H., Yurdaydin, C. and Uzunalimoglu, O. (2005) Thrombophilic Gene Mutations in Cirrhotic Patients with Portal Vein Thrombosis. European Journal of Gastroenterology & Hepatology, 17, 339-343. https://doi.org/10.1097/00042737-200503000-00013
|
[25]
|
Tripodi, A., Primignani, M., Chantarangkul, V., et al. (2009) An Imbalance of Pro- vs Anti-Coagulation Factors in Plasma from Patients with Cirrhosis. Gastroenterology, 137, 2105-2111. https://doi.org/10.1053/j.gastro.2009.08.045
|
[26]
|
Gatt, A., Riddell, A., Calvaruso, V., Tuddenham, E.G., Makris, M. and Burroughs, A.K. (2010) Enhanced Thrombin Generation in Patients with Cirrhosis-Induced Coagulopathy. Journal of Thrombosis and Haemostasis, 8, 1994-2000. https://doi.org/10.1111/j.1538-7836.2010.03937.x
|
[27]
|
Hugenholtz, G.C., Macrae, F., Adelmeijer, J., et al. (2016) Procoagulant Changes in Fibrin Clot Structure in Patients with Cirrhosis Are Associated with Oxidative Modifications of Fibrinogen. Journal of Thrombosis and Haemostasis, 14, 1054-1066. https://doi.org/10.1111/jth.13278
|
[28]
|
Ambrosino, P., Tarantino, L., Di Minno, G., et al. (2017) The Risk of Ve-nous Thromboembolism in Patients with Cirrhosis. A Systematic Review and Meta-Analysis. Thrombosis and Haemo-stasis, 117, 139-148. https://doi.org/10.1160/TH16-06-0450
|
[29]
|
Lancellotti, S., Basso, M., Veca, V., Sacco, M., Riccardi, L., Pompili, M. and De Cristofaro, R. (2016) Presence of Portal Vein Thrombosis in Liver Cirrhosis Is Strongly Associated with Low Levels of ADAMTS-13: A Pilot Study. Internal and Emergency Medicine, 11, 959-967. https://doi.org/10.1007/s11739-016-1467-x
|
[30]
|
Miku?a, T., Koz?owska, J., Stańczak, W., Sapu?a, M., Ró?yk, A. and Wiercińska-Drapa?o, A. (2018) Serum ADAMTS-13 Levels as an Indicator of Portal Vein Thrombosis. Gastroen-terology Research and Practice, 2018, Article ID: 3287491. https://doi.org/10.1155/2018/3287491
|
[31]
|
Carnevale, R., Raparelli, V., Nocella, C., Bartimoccia, S., Novo, M., Severino, A., De Falco, E., Cammisotto, V., Pasquale, C., Crescioli, C., Scavalli, A.S., Riggio, O., Basili, S. and Violi, F. (2017) Gut-Derived Endotoxin Stimulates Factor VIII Secretion from Endothelial Cells. Implications for Hypercoagulability in Cirrhosis. Journal of Hepatology, 67, 950-956. https://doi.org/10.1016/j.jhep.2017.07.002
|
[32]
|
Violi, F., Ferro, D., Basili, S., Lionetti, R., Rossi, E., Merli, M., Riggio, O., Bezzi, M. and Capocaccia, L. (1997) Ongoing Prothrombotic State in the Portal Circulation of Cirrhotic Patients. Thrombosis and Haemostasis, 77, 44-47. https://doi.org/10.1055/s-0038-1655904
|
[33]
|
Wosiewicz, P., ?orniak, M., Hartleb, M., Barański, K., Hartleb, M., Onyszczuk, M., Pilch-Kowalczyk, J. and Kyrcz-Krzemień, S. (2016) Portal Vein Thrombosis in Cirrhosis Is Not Asso-ciated with Intestinal Barrier Disruption or Increased Platelet Aggregability. Clinics and Research in Hepatology and Gastroenterology, 40, 722-729. https://doi.org/10.1016/j.clinre.2016.03.008
|
[34]
|
Amitrano, L., Guardascione, M.A., Brancaccio, V., Margaglione, M., Manguso, F., Iannaccone, L., Grandone, E. and Balzano, A. (2004) Risk Factors and Clinical Presentation of Portal Vein Thrombosis in Patients with Liver Cirrhosis. Journal of Hepatology, 40, 736-741. https://doi.org/10.1016/j.jhep.2004.01.001
|
[35]
|
Bagheri Lankarani, K., Homayon, K., Motevalli, D., Heidari, S.T., Alavian, S.M. and Malek-Hosseini, S.A. (2015) Risk Factors for Portal Vein Thrombosis in Patients With Cirrhosis Awaiting Liver Transplantation in Shiraz, Iran. Hepatitis Monthly, 15, e26407. https://doi.org/10.5812/hepatmon.26407
|
[36]
|
Qi, X., Han, G., Ye, C., Zhang, Y., Dai, J., Peng, Y., Deng, H., Li, J., Hou, F., Ning, Z., Zhao, J., Zhang, X., Wang, R. and Guo, X. (2016) Splenectomy Causes 10-Fold Increased Risk of Portal Venous System Thrombosis in Liver Cirrhosis Patients. Medical Science Monitor, 22, 2528-2550. https://doi.org/10.12659/MSM.898866
|
[37]
|
Politoske, D., Ralls, P. and Korula, J. (1996) Portal Vein Thrombosis Following Endoscopic Variceal Sclerotherapy. Prospective Controlled Comparison in Patients with Cirrhosis. Digestive Diseases and Sciences, 41, 185-190. https://doi.org/10.1007/BF02208603
|